• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Vitamin B17 and the Laetrile Controversy: Claims, Cancer Research, Regulation, and the History of an Alternative Therapy

Vitamin B17 and the Laetrile Controversy: Claims, Cancer Research, Regulation, and the History of an Alternative Therapy

Paperback

Medical ReferenceGeneral Alternative Health

ISBN13: 9798191500690
Publisher: Independently Published
Published: Aug 8 2026
Pages: 46
Weight: 0.17
Height: 0.10 Width: 6.00 Depth: 9.00
Language: English
Vitamin B17 and the Laetrile Controversy examines one of the most persistent disputes in modern cancer history: the claim that amygdalin, often marketed as vitamin B17 or laetrile, represents a suppressed nutritional answer to cancer.

Rather than repeating the controversy as either a miracle-cure story or a caricature, Marco Polanowsky reconstructs its major arguments and places them beside what current evidence can actually support. The book explores the deficiency theory of cancer, traditional-diet claims, trophoblast and enzyme theories, apricot-kernel toxicity, patient testimonials, the NCI clinical studies, criticism of surgery and chemotherapy, disputes involving Sloan-Kettering, FDA regulation, the Flexner era of medical education, pharmaceutical incentives, Rockefeller philanthropy, I.G. Farben, media framing, and the broader politics of medical dissent.

The result is a readable case study in evidence, hope, institutional trust, commercial incentives, and the way controversial medical ideas spread. It is written for readers interested in cancer history, alternative medicine, medical policy, and critical thinking.

This is a critical historical analysis, not a treatment manual. It does not recommend laetrile, amygdalin, apricot kernels, or any supplement as a cancer therapy.

Also from

Polanowsky, Marco

Also in

Medical Reference